Fulgent Genetics Stock Market Value
| FLGT Stock | USD 18.33 0.46 2.57% |
| Symbol | Fulgent |
Fulgent Genetics Price To Book Ratio
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (5.52) | Revenue Per Share 9.255 | Quarterly Revenue Growth (0.15) | Return On Assets (0.04) |
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Fulgent Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fulgent Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fulgent Genetics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Fulgent Genetics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Fulgent Genetics or generate 0.0% return on investment in Fulgent Genetics over 30 days. Fulgent Genetics is related to or competes with Illumina, T2 Biosystms, Agilent Technologies, Mettler Toledo, Waters, Danaher, and Thermo Fisher. Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing ser... More
Fulgent Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fulgent Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fulgent Genetics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 17.58 | |||
| Value At Risk | (3.86) | |||
| Potential Upside | 3.14 |
Fulgent Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fulgent Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fulgent Genetics' standard deviation. In reality, there are many statistical measures that can use Fulgent Genetics historical prices to predict the future Fulgent Genetics' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.46) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.43) |
Fulgent Genetics Backtested Returns
Fulgent Genetics secures Sharpe Ratio (or Efficiency) of -0.13, which denotes the company had a -0.13% return per unit of risk over the last 3 months. Fulgent Genetics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fulgent Genetics' Standard Deviation of 2.69, variance of 7.23, and Mean Deviation of 2.06 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.84, which means possible diversification benefits within a given portfolio. As returns on the market increase, Fulgent Genetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Fulgent Genetics is expected to be smaller as well. At this point, Fulgent Genetics has a negative expected return of -0.35%. Please make sure to confirm Fulgent Genetics' value at risk, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Fulgent Genetics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.74 |
Almost perfect reverse predictability
Fulgent Genetics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Fulgent Genetics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fulgent Genetics price movement. The serial correlation of -0.74 indicates that around 74.0% of current Fulgent Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.74 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.95 |
Fulgent Genetics lagged returns against current returns
Autocorrelation, which is Fulgent Genetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fulgent Genetics' stock expected returns. We can calculate the autocorrelation of Fulgent Genetics returns to help us make a trade decision. For example, suppose you find that Fulgent Genetics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Fulgent Genetics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fulgent Genetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fulgent Genetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fulgent Genetics stock over time.
Current vs Lagged Prices |
| Timeline |
Fulgent Genetics Lagged Returns
When evaluating Fulgent Genetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fulgent Genetics stock have on its future price. Fulgent Genetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fulgent Genetics autocorrelation shows the relationship between Fulgent Genetics stock current value and its past values and can show if there is a momentum factor associated with investing in Fulgent Genetics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.